OKYO
Price
$2.46
Change
+$0.04 (+1.65%)
Updated
Jun 27 closing price
Capitalization
91.69M
36 days until earnings call
POLBF
Price
$0.04
Change
-$0.08 (-66.67%)
Updated
May 22 closing price
Capitalization
31.57M
Interact to see
Advertisement

OKYO vs POLBF

Header iconOKYO vs POLBF Comparison
Open Charts OKYO vs POLBFBanner chart's image
OKYO Pharma
Price$2.46
Change+$0.04 (+1.65%)
Volume$40.52K
Capitalization91.69M
Poolbeg Pharma
Price$0.04
Change-$0.08 (-66.67%)
Volume$50K
Capitalization31.57M
OKYO vs POLBF Comparison Chart in %
Loading...
OKYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
POLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OKYO vs. POLBF commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OKYO is a Buy and POLBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (OKYO: $2.46 vs. POLBF: $0.04)
Brand notoriety: OKYO and POLBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OKYO: 21% vs. POLBF: 183%
Market capitalization -- OKYO: $91.69M vs. POLBF: $31.57M
OKYO [@Biotechnology] is valued at $91.69M. POLBF’s [@Biotechnology] market capitalization is $31.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OKYO’s FA Score shows that 0 FA rating(s) are green whilePOLBF’s FA Score has 1 green FA rating(s).

  • OKYO’s FA Score: 0 green, 5 red.
  • POLBF’s FA Score: 1 green, 4 red.
According to our system of comparison, both OKYO and POLBF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OKYO’s TA Score shows that 2 TA indicator(s) are bullish while POLBF’s TA Score has 2 bullish TA indicator(s).

  • OKYO’s TA Score: 2 bullish, 6 bearish.
  • POLBF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, POLBF is a better buy in the short-term than OKYO.

Price Growth

OKYO (@Biotechnology) experienced а +3.80% price change this week, while POLBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

OKYO is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OKYO($91.7M) has a higher market cap than POLBF($31.6M). OKYO YTD gains are higher at: 113.932 vs. POLBF (-64.407).
OKYOPOLBFOKYO / POLBF
Capitalization91.7M31.6M290%
EBITDAN/AN/A-
Gain YTD113.932-64.407-177%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
OKYOPOLBF
RSI
ODDS (%)
Bearish Trend 4 days ago
74%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
79%
N/A
Momentum
ODDS (%)
Bearish Trend 4 days ago
74%
Bullish Trend 4 days ago
22%
MACD
ODDS (%)
Bearish Trend 4 days ago
61%
Bullish Trend 4 days ago
14%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
56%
Bullish Trend 4 days ago
10%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
55%
Bullish Trend 4 days ago
10%
Advances
ODDS (%)
Bullish Trend 11 days ago
87%
N/A
Declines
ODDS (%)
Bearish Trend 14 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
21%
View a ticker or compare two or three
Interact to see
Advertisement
OKYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
POLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LFGP14.700.32
+2.23%
Ledyard Financial Group, Inc.
ATOXF0.11N/A
+1.11%
Quantum Critical Metals Corp
FURCF9.33N/A
N/A
FORVIA SE
STGXF6.21N/A
N/A
Smartgroup Corp Ltd.
NIOIF3.45-0.15
-4.17%
NIO Inc.

OKYO and

Correlation & Price change

A.I.dvisor tells us that OKYO and ACUT have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OKYO and ACUT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OKYO
1D Price
Change %
OKYO100%
+1.44%
ACUT - OKYO
28%
Poorly correlated
+10.61%
XRTX - OKYO
28%
Poorly correlated
+13.10%
DYN - OKYO
27%
Poorly correlated
-4.78%
VXRT - OKYO
27%
Poorly correlated
-7.14%
NXTC - OKYO
26%
Poorly correlated
-0.61%
More

POLBF and

Correlation & Price change

A.I.dvisor tells us that POLBF and VSTM have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POLBF and VSTM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To POLBF
1D Price
Change %
POLBF100%
N/A
VSTM - POLBF
29%
Poorly correlated
-0.24%
NNVC - POLBF
24%
Poorly correlated
+13.82%
SNSE - POLBF
24%
Poorly correlated
+3.58%
ALXO - POLBF
20%
Poorly correlated
-10.34%
OKYO - POLBF
12%
Poorly correlated
+1.44%
More